Applied Spine Technologies Announces Two Year Milestone for First Series of Patients with Stabilimax® Dynamic Spine Stabilization System

NEW HAVEN, Conn.–(BUSINESS WIRE)–Applied Spine Technologies (AST), Inc. (www.appliedspine.com), a medical device company focused on motion preservation of the lumbar spine, announced today that their initial cohort of 15 Stabilimax System patients have reached the 24 month mark in the ongoing clinical trial. The Stabilimax System is a posterior dynamic stabilization device designed to support an injured or degenerative spine without eliminating motion.

“It is encouraging to see such significant progress within the Stabilimax IDE,” said Craig Corrance, CEO of Applied Spine Technologies. “The two year product milestone marks an exciting moment in the companies’ history and reinforces our strategy for the future commercialization of the Stabilimax System.”